Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAPN15 antisense RNA 1 (CAPN15-AS1)
- Target
- CAPN15-AS1
- Molecular classification
- Other (Long non-coding RNA; Natural antisense RNA)
01
Overview
CAPN15 antisense RNA 1 (CAPN15-AS1) is a natural long non-coding RNA (lncRNA) transcribed from the strand opposite the CAPN15 gene. Natural antisense RNAs like CAPN15-AS1 are regulatory non-coding RNAs that can influence the expression of their sense gene (here, CAPN15), possibly modulating gene expression at the level of transcription, mRNA stability, or splicing[2][3]. While CAPN15-AS1 has been catalogued in genomic studies and lncRNA databases, specific biological and disease functions for this antisense RNA have not yet been characterized in the literature. Current studies indicate that natural antisense lncRNAs in general can regulate their sense counterparts or contribute to cell-type- or disease-specific gene regulatory networks, but there is no direct evidence associating CAPN15-AS1 with disease or as a drug target[2][3].
- Other names
- CAPN15-AS1CAPN15 antisense RNA 1
02
Mechanism of action
Not targeted directly by drugs; lncRNAs/antisense RNAs can regulate expression of complementary genes via transcriptional interference, chromatin remodeling, and mRNA stability
03
Biological functions
Regulation of gene expressionControl of mRNA stabilityModulation of transcriptionPotential involvement in splicing and epigenetic regulation
04
Disease associations
Other (General lncRNAs, including antisense RNAs, have been implicated in oncogenesis, but there is no direct evidence available for CAPN15-AS1 specifically in a given disease)
Beyond the preview
Go deeper on CAPN15 antisense RNA 1 (CAPN15-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CAPN15 antisense RNA 1 (CAPN15-AS1).